<?xml version="1.0" encoding="UTF-8" standalone="yes"?>

<!-- Copyright (c) 2004-2026 Broad Institute, Inc., Massachusetts Institute of Technology, and Regents of the University of California.  All rights reserved.
     See license terms at www.gsea-msigdb.org/gsea/license_terms_list. Please note that certain gene sets have special access terms.
-->
<MSIGDB BUILD_DATE="Jan 29, 2026" VERSION="2026.1.Hs" NAME="export">
    <GENESET STANDARD_NAME="OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP" SYSTEMATIC_NAME="M40906" HISTORICAL_NAMES="" PMID="27441275" AUTHORS="Ovsyannikova IG,Oberg AL,Kennedy RB,Zimmermann MT,Haralambieva IH,Goergen KM,Grill DE,Poland GA" GEOID="" EXACT_SOURCE="Suppl Table 1" GENESET_LISTING_URL="" EXTERNAL_DETAILS_URL="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946173/bin/mmc1.docx" CHIP="HUMAN_GENE_SYMBOL" CONTRIBUTOR="HIPC SIGNATURES" CONTRIBUTOR_ORG="NIAID/HIPC SIGNATURES" DESCRIPTION_BRIEF="Genes up-regulated in peripheral blood mononuclear cell responders vs nonresponders in adults (55-64) after exposure to Fluarix , time point 28D. Comment: Gene expression related to HAI response" DESCRIPTION_FULL="To assess gene signatures related to humoral response among healthy older subjects following seasonal influenza vaccination, we studied 94 healthy adults (50-74 years old) who received one documented dose of licensed trivalent influenza vaccine containing the A/California/7/2009 (H1N1)-like virus strain. Influenza-specific antibody (HAI) titer in serum samples and next-generation sequencing on PBMCs were performed using blood samples collected prior to (Day 0) and at two timepoints after (Days 3 and 28) vaccination. We identified a number of uncharacterized genes (ZNF300, NUP1333, KLK1 and others) and confirmed previous studies demonstrating specific genes/genesets that are important mediators of host immune responses and that displayed associations with antibody response to influenza A/H1N1 vaccine. These included interferon-regulatory transcription factors (IRF1/IRF2/IRF6/IRF7/IRF9), chemokine/chemokine receptors (CCR5/CCR9/CCL5), cytokine/cytokine receptors (IFNG/IL10RA/TNFRSF1A), protein kinases (MAP2K4/MAPK3), growth factor receptor (TGFBR1). The identification of gene signatures associated with antibody response represents an early stage in the science for which further research is needed. Such research may assist in the design of better vaccines to facilitate improved defenses against new influenza virus strains, as well as better understanding the genetic drivers of immune responses." TAGS="" MEMBERS="ARHGEF10,ATP13A4,CUL1,GRPEL2,KAT2B,MBTPS1,MIR155HG,PHF2,SCRIB" MEMBERS_SYMBOLIZED="ARHGEF10,ATP13A4,CUL1,GRPEL2,KAT2B,MBTPS1,MIR155HG,PHF2,SCRIB" MEMBERS_EZID="114614,134266,23513,5253,84239,8454,8720,8850,9639" MEMBERS_MAPPING="ARHGEF10,ARHGEF10,9639|ATP13A4,ATP13A4,84239|CUL1,CUL1,8454|GRPEL2,GRPEL2,134266|KAT2B,KAT2B,8850|MBTPS1,MBTPS1,8720|MIR155HG,MIR155HG,114614|PHF2,PHF2,5253|SCRIB,SCRIB,23513" FILTERED_BY_SIMILARITY="" FOUNDER_NAMES="" REFINEMENT_DATASETS="" VALIDATION_DATASETS="" CATEGORY_CODE="C7" ORGANISM="Homo sapiens" SUB_CATEGORY_CODE="VAX"/>
</MSIGDB>
